FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency. | The FDA’s Chief Medical Officer ...
Investor's Business Daily on MSN1d
Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass FiringsBiotech stocks skidded again Tuesday as "chaos" reigned at the FDA with reports of mass firings, including the departure of a ...
Epicrispr Biotechnologies Announces FDA Clearance of IND Application for EPI-321, A First-in-Class Epigenetic Therapy for FSHD ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
As director of the FDA's Center for Biologics Evaluation and Research, Marks has publicly supported programs that expedited ...
In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...
Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
2d
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback